New research indicates that patients who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who halt conventional lifestyle plans.
Published data in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these treatments should be cognizant of the danger of rapid rebound weight gain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
That rate of regain means a return to original weight within about one and a half years.
Analyzing Treatments
The study, which looked at 37 of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with older methods.
Researchers point out that individuals who shed pounds through diet and exercise usually experience a slower creep back—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Rebound
Doctors believe the mechanism of the injections is key to understanding the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Sustained high doses of the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making binge eating far more likely."
An Ongoing Disease?
Health authorities advise the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals argue that, given the likelihood of weight regain, the therapy is often life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "highlight the long-term nature of excess weight," akin to managing diseases like diabetes.
User Experiences
Users who have stopped the medication describe a sudden return of cravings.
"I experienced a trigger flipping and you become ravenous," recalled one woman.
The struggle is worsened if individuals have not established permanent dietary or behavioural changes during treatment.
Growing Adoption
Survey data indicate that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Adoption is greater among women than males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
Ultimately, researchers stress that while these medications are potent agents for weight loss, they are not a magic solution and maintained weight loss hinges on ongoing lifestyle changes.
